CIK 0000944809
- Accelerated filer
OPKO HEALTH, INC.
Sign in to watch- Ticker
- OPK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752402409
- Phone
- +1 305-575-4181
- Business address
- 4400 BISCAYNE BLVD., MIAMI, FL, 33137
- Former names
- EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
- 4 Grant or award Sr. Vice President, CFO acquired 437,500 shares (grant or award)
- 4 Grant or award Executive VP-Administration acquired 437,500 shares (grant or award)
- 4 Grant or award Vice Chairman and President acquired 500,000 shares (grant or award)
- 4 Grant or award Chief Innovation Officer acquired 437,500 shares (grant or award)
- 4 Open-market sale 10% owner sold 150,000 shares at an average $32.98 ($4,946,935)
- 4 Open-market sale 10% owner sold 25,000 shares at $32.93 ($823,188)
- 4 Open-market sale 10% owner sold 36,118 shares at $28.24 ($1,020,016)
- 4 Planned sale 10% owner sold 89,082 shares at an average $27.58 ($2,457,286)
- 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $1.27 ($126,937)
- 4 Open-market buy CEO & Chairman bought 163,997 shares at $1.29 ($211,195)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Open-market buy CEO & Chairman bought 500,000 shares at $0.87 ($437,100)
- 4 Open-market buy CEO & Chairman bought 500,000 shares at $0.89 ($444,300)
- 4 Open-market buy CEO & Chairman bought 500,000 shares at $0.93 ($463,750)
- 4 Open-market buy CEO & Chairman bought 600,000 shares at $0.93 ($559,380)
Page 4 of 106 · 2,118 filings